SVF's innovative platform for vaccine development has been developed by researchers at Karolinska Institutet who has an extensive experience in vaccine development and in particular DNA- and mRNA-based vaccines. The unique concept of combining different viral genes to generate both neutralizing antibodies and T cells enables the immune system to effectively fight the infection.